WEDNESDAY, March 23, 2022 (HealthDay News) — Uninsured Americans will no longer be covered for free COVID-19 tests and treatments because of the budget impasse in Congress, a Biden administration official said Tuesday.

The program was to stop accepting claims at midnight Tuesday, according to Martin Kramer, a spokesman for the Health Resources and Services Administration, the Associated Press reported. “The lack of funding for COVID-19 needs is having real consequences,” Kramer said in a statement. “We have begun an orderly shutdown of the program.” After April 5, the program will have to stop accepting claims for vaccination-related costs, Kramer warned.

The program, which reimburses hospitals, clinics, doctors, and other service providers for COVID-19 care for uninsured people, is a victim of the budget battle over Biden’s request for an additional $22.5 billion for an ongoing COVID-19 response, the AP reported. A fact sheet from the White House details further potential fallout from the lack of funding.

It says the government will not have enough money to provide boosters or vaccines targeting specific variants to all Americans, while the supply of monoclonal antibody treatments will be gone by late May. Additionally, certain treatments needed by patients with immune system problems could soon be hard to get, and continuing a robust COVID-19 testing will again become a challenge.

“COVID is a highly infectious disease, so we want people who think they might be sick to get tested and treated, not only for their health but for the community as well,” Larry Levitt, a health policy expert with the nonpartisan Kaiser Family Foundation, told the AP. “If uninsured people now hesitate to get care because of the cost, we’ll see more cases and greater inequity.”

Another concern is that vaccine providers may reduce their outreach efforts to uninsured people, according to Levitt. There are about 28 million uninsured people in the United States, the AP reported.

Associated Press Article

Copyright © 2021 HealthDay. All rights reserved.